Gilead Sciences Inc. must face a fired employee’s lawsuit alleging its response to a co-worker’s false sexual harassment ...

but—even by its own standards—the decision to split in two while waving goodbye to 40% of its employees and a long-standing Gilead Sciences partnership is a bold move. The split will leave one ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

As a result, high computing performance can be ensured even in large-scale learning jobs, further reducing the time and ... GAAP diluted earnings per share for Q4 2024 was $0.77 compared to... Gilead ...

This strategic change also has implications for the terms of Galapagos' 2019 licensing agreement with Gilead Sciences. The agreement was initially set to last a decade and gave Gilead rights to six ...

The 1980s was a decade known for the birth of the last of Generation X and big-hair bands. It also produced some of the best ...

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Gilead Sciences (GILD – Research Report), with a price ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

Investors with a lot of money to spend have taken a bullish stance on Gilead Sciences GILD. And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance ...